Triggering the adaptive immune system with commensal gut bacteria protects against insulin resistance and dysglycemia

Autor: Frédéric Lopez, Céline Pomié, Anthony Puel, Vincent Blasco-Baque, Lucile Garidou, Philippe Valet, Michael Courtney, Rémy Burcelin, Aurélie Waget, Jacques Amar, Vincent Azalbert, Benjamin Lelouvier, Florence Servant, Pascale Klopp, Simon Nicolas, Cédric Dray, Pascale Loubieres
Rok vydání: 2016
Předmět:
0301 basic medicine
lcsh:Internal medicine
LN
Lymph nodes

endocrine system diseases
T2D
Type 2 diabetes

Adipose tissue
chemical and pharmacologic phenomena
030209 endocrinology & metabolism
Type 2 diabetes
Biology
Gut flora
digestive system
03 medical and health sciences
0302 clinical medicine
Insulin resistance
APC
Antigen presenting cells

Immunity
medicine
lcsh:RC31-1245
Antigen-presenting cell
Molecular Biology
digestive
oral
and skin physiology

nutritional and metabolic diseases
Cell Biology
biochemical phenomena
metabolism
and nutrition

medicine.disease
biology.organism_classification
Acquired immune system
Gut microbiota and metabolic diseases
AT
Adipose tissue

Crosstalk (biology)
030104 developmental biology
VL
Vastus lateralis muscle

Immunology
bacteria
Original Article
NC
Normal chow
Zdroj: Molecular Metabolism
Molecular Metabolism, Vol 5, Iss 6, Pp 392-403 (2016)
ISSN: 2212-8778
Popis: Objective To demonstrate that glycemia and insulin resistance are controlled by a mechanism involving the adaptive immune system and gut microbiota crosstalk. Methods We triggered the immune system with microbial extracts specifically from the intestinal ileum contents of HFD-diabetic mice by the process of immunization. 35 days later, immunized mice were fed a HFD for up to two months in order to challenge the development of metabolic features. The immune responses were quantified. Eventually, adoptive transfer of immune cells from the microbiota-immunized mice to naïve mice was performed to demonstrate the causality of the microbiota-stimulated adaptive immune system on the development of metabolic disease. The gut microbiota of the immunized HFD-fed mice was characterized in order to demonstrate whether the manipulation of the microbiota to immune system interaction reverses the causal deleterious effect of gut microbiota dysbiosis on metabolic disease. Results Subcutaneous injection (immunization procedure) of ileum microbial extracts prevented hyperglycemia and insulin resistance in a dose-dependent manner in response to a HFD. The immunization enhanced the proliferation of CD4 and CD8 T cells in lymphoid organs, also increased cytokine production and antibody secretion. As a mechanism explaining the metabolic improvement, the immunization procedure reversed gut microbiota dysbiosis. Finally, adoptive transfer of immune cells from immunized mice improved metabolic features in response to HFD. Conclusions Glycemia and insulin sensitivity can be regulated by triggering the adaptive immunity to microbiota interaction. This reduces the gut microbiota dysbiosis induced by a fat-enriched diet.
Highlights • Triggering adaptive immune response with ileum bacteria extracts prevents HFD-induced metabolic disease. • Triggering adaptive immune response with ileum bacteria extracts improves gut microbiota dysbiosis. • Triggering adaptive immune response with ileum bacteria extract regulates the intestinal immune system. • First microbiota based vaccination strategy of metabolic disease.
Databáze: OpenAIRE